SCHEMBL14701011

SCHEMBL14701011

O=C1CCc2c1n(P)c1ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
CREBBP Q92793 1/20 0.51
ALDH1A1 P00352 1/20 0.43
TSHR P16473 1/20 0.43
MAOA P21397 4/20 0.41
ALOX15 P16050 2/20 0.41
MAPK1 P28482 2/20 0.41
MAPT P10636 1/20 0.41
MAOB P27338 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
PABPC1 P11940 1/20 0.36
PDE5A O76074 2/20 0.35
HSD17B10 Q99714 1/20 0.35
HTR6 P50406 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8792194 0.79 ALDH1A1 (0.62) TP53CREBBPALDH1A1TSHRMAOA
SCHEMBL16201673 0.75 TP53 (0.51) TP53CREBBPALDH1A1TSHRMAOA
SCHEMBL7250388 0.73 TP53 (0.50) TP53CREBBPALDH1A1TSHRMAOA
SCHEMBL17895740 0.69 KDM4E (0.61) TP53CREBBPALDH1A1TSHRMAOA
SCHEMBL22118133 0.69 KDM4E (0.66) TP53CREBBPALDH1A1TSHRMAOA
SCHEMBL30223561 0.69 KDM4E (0.66) TP53CREBBPALDH1A1TSHRMAOA
SCHEMBL5322539 0.68 TP53 (1.00) TP53CREBBPALDH1A1TSHRMAPK1
SCHEMBL30395130 0.68 TP53 (1.00) TP53CREBBPALDH1A1TSHRMAPK1
SCHEMBL8791684 0.67 TP53 (0.60) TP53CREBBPALDH1A1TSHRALOX15
SCHEMBL13374381 0.66 GPR3 (0.52) ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170121285-A1 Selective androgen receptor modulators RADIUS HEALTH INC (US) 2017-05-04 US disclosed
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS RADIUS HEALTH INC (US) 2015-09-24 US disclosed
US-8987319-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2015-03-24 US disclosed
US-20130041007-A1 Selective Androgen Receptor Modulators RADIUS HEALTH, INC. 2013-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170121285-A1 Selective androgen receptor modulators AR, SHBG, FSHR TP53 1244/4885CREBBP 2874/4885ALDH1A1 1511/4885
US-20150266821-A1 SELECTIVE ANDROGEN RECEPTOR MODULATORS AR, SHBG, FSHR TP53 1247/4885CREBBP 2880/4885ALDH1A1 1542/4885
US-20130041007-A1 Selective Androgen Receptor Modulators AR, SHBG, GPR119 TP53 1188/4885CREBBP 2943/4885ALDH1A1 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.